Loading...
Found 17 Leukemia trials
A listing of Leukemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
B
Brian Weiss
This study investigates the safety and best dose of an investigational medication combined with chemotherapy drugs, fludarabine and cytarabine, for treating certain blood cancers. The cancers include acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and juvenile myelomonocytic leukemia (JMML) that have not responded to previous treatment or have returned after …
S
Sandeep Batra, MD
This study investigates the treatment of acute myeloid leukemia (AML) in children, adolescents, and young adults who have experienced a relapse. The purpose is to see if adding an investigational medication to a standard chemotherapy treatment can improve outcomes. Acute myeloid leukemia is a type of cancer that affects the …
S
Sandeep Batra, MD
This study investigates treatments for a type of blood cancer called Philadelphia chromosome-positive or ABL-class Philadelphia chromosome-like B-cell acute lymphoblastic leukemia (B-ALL). B-ALL is a cancer of the white blood cells. The study looks at the effects of combining blinatumomab, a special antibody that helps the immune system fight cancer, …
S
Sandeep Batra, MD
This study investigates the effects of two investigational medications, blinatumomab and nivolumab, in patients with B-cell acute lymphoblastic leukemia (B-ALL) that has relapsed. B-ALL is a type of cancer that affects the white blood cells. The study includes patients with Down syndrome and aims to compare the outcomes of using …
R
Rachael Schulte
What is the purpose of this study?The aim of this study is to support development of asciminib in the pediatric population (1 to <18 years) with Philadelphia chromosome positive chronic myeloid leukemia in chronic phase (PH+ CML-CP) previously treated with one or more Tyrosine kinase inhibitor (TKIs). THIS STUDY IS ENROLLING …
J
Jodi Skiles
What is the purpose of this study?A Phase I trial to determine the safety of targeted immunotherapy with daratumumab (DARA) IV after total body irradiation (TBI)-based myeloablative conditioning and allogeneic hematopoietic cell transplantation (HCT) for children, adolescents, and young adults (CAYA) with high risk T-cell acute lymphoblastic leukemia (T-ALL) or …
S
Sherif Farag, MD
This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and otherdications.
Please choose between Voice or SMS based delivery of verification code
or